April 1, 2022
ConcertAI, a Startup Focused on Cancer Research, Raises $150 Million
NEWS Media Coverage
29-Mar-2022 by Brian Gormley
(May Require Subscription)
The firm uses AI to match patients to specific clinical trials, and to make jumbled medical data AI-ready to sift for more insights. Sixth Street provided funding that values the firm at $1.9 billion.
ConcertAI LLC has raised $150 million to expand a business that uses software and data to help speed clinical research into different types of cancer and to match patients with clinical trials and medications.Read More